Esbjörner Winters Lab

Our research focuses on understanding how protein misfolding and protein self-assembly contribute to the pathology of neurodegenerative disorders such as Alzheimer’s disease.

Image 1 of 1

Elin Esbjörner's group uses tools of biophysics and biochemistry in combination with live cell imaging, cell- and molecular biology to study the formation of amyloid fibrils and neurotoxic protein aggregates in vitro and in cellular models of human disease.

Group members

Research group leader

Elin Esbjörner Winters

  • Head of Division, Molecular Bioscience, Life Sciences
To personal page

Researcher

Postdoc

PhD student

Nima Sasanian

  • Research Engineer, Chalmers Next Labs AB
To personal page

Vesa Halipi

  • Visiting Researcher, Molecular Bioscience, Life Sciences
To personal page

Fritjof Havemeister

  • Doctor, Molecular Bioscience, Life Sciences
To personal page

Andrea Ramnath

  • Doctoral Student, Molecular Bioscience, Life Sciences
To personal page

Elin Persson

  • Doctoral Student, Molecular Bioscience, Life Sciences
To personal page

Viktoria de Carvalho

  • Doctoral Student, Molecular Bioscience, Life Sciences
To personal page

MSc student

Group leader

Elin Esbjörner Winters

  • Head of Division, Molecular Bioscience, Life Sciences
To personal page

You may also be interested in

1 of 3

  • FormulaEx
    nano

    FormulaEx

    The Formulaex centre is a SSF-funded industrial research centre for functional RNA delivery. The three academic partners Chalmers University of Technology, Karolinska Institutet and University of Gothenburg carry out research in close cooperation with AstraZeneca, Vironova, Camarus and Nanolyze. The centre contributes with fundamental knowledge required for the design of safe and efficient nanoscale drug-delivery vehicles for next generation nucleotide drugs.

    Read more
  • Monitoring mRNA to time its great escape perfectly
    research

    Monitoring mRNA to time its great escape perfectly

    ​​The ease by which mRNA-based drugs are taken up by cells in tissues is crucial to their therapeutic effectiveness. Now, a new detection method developed by researchers at Chalmers and AstraZeneca could lead to faster and better development of the small droplets known as lipid nanoparticles, which are the main method used to package mRNA for delivery to the cells.​

    Read more
  • Health Engineering Area of Advance
    health

    Health Engineering Area of Advance

    Addresses major health-related societal challenges by developing new technologies and innovative solutions in close collaboration with healthcare and industry.

    Read more